baber/WOPTO huggingface dataset:
Patent AT-E181031-T1 (AT)
Inventor: HARRIS RANDALL
IPC: B65D5/02
Filed: 1994-08-11
Granted: 1999-06-15
Abstract: A carrier having an end panel construction that snaps into place during formation of the carrier and has the ability to follow the contour of adjacent curved or beveled packaged articles. Gusset panels or tabs foldably connected to the lower end panel flap and adjacent glue flaps cause the flaps to snap into place. A bevel panel between the glue flaps and the side panels or dual angled fold lines connecting the glue flaps to the side panels enable the carrier to tightly follow the contour of curved corner articles in the carrier.
Patent AT-E149057-T1 (AT)
Inventor: HETZEL WALTER DIPL ING
IPC: F04B13/00
Filed: 1995-04-28
Granted: 1997-03-15
Abstract: The dosing pump has a pump chamber with a volume which is enlarged during the suction stroke and reduced during the compression stroke, with a venting valve (17, 18) at the upper end of the pump chamber. The response characteristics of the venting valve are dependent on the aggregate characteristics of the dosed medium. The venting value is preceded by a back-feed prevention valve (16, 18) in the flow direction from the pump chamber, the back-feed prevention valve normally held closed and only opened in response to the fluid flow from the pump chamber.
Patent AT-E187155-T1 (AT)
Inventor: WEIGUNY JENS DR
IPC: B01J23/14
Filed: 1995-08-28
Granted: 1999-12-15
Abstract: The prodn. of aldehydes (I) comprises catalytically hydrogenating a carboxylic acid or deriv. (II) in the gas phase at elevated temp. in the presence of a Sn catalyst supported on an oxide carrier.
Patent AT-E221201-T1 (AT)
Inventor: FURUTA TAKAHISA DR
IPC: G01N33/53
Filed: 1995-09-29
Granted: 2002-08-15
Abstract: A method of judging the eradication of H. pylori to judge whether the sample is positive or negative through a quick and easily operation is provided. A PG I value and a PG II value in the body fluids (e.g., in the blood) of an H. pylori positive patient are measured before the H. pylori eradicating treatment and after the passage of a period in which a substantially significant result occurs from the eradicating treatment, a PG I/PG II ratio in the body fluids (e.g., in the blood) is found, a rate of change in the PG I/PG II ratio in the body fluids (e.g., in the blood) is found before the H. pylori eradicating treatment and after the passage of the period in which a substantially significant result occurs from the eradicating treatment, and the change in the PG I/PG II ratio is used as a marker to indicate that H. pylori is eradicated.
Patent AT-E186533-T1 (AT)
Inventor: CHARPENTIER BRUNO
IPC: A61K8/00
Filed: 1995-09-11
Granted: 1999-11-15
Abstract: Dibenzofuran derivs. of formula (I), their optical and geometric isomers and salts are new. Ar = a gp. of formula (II)-(VI); M = CR5R6, -C(O)-CH=CH-, -C(O)-C  IDENTICAL  C-, -C(=Y)-W-CH2-, -CR5R6-CH2-W-, R5R6C, -CH=CH-C(O)-, -C  IDENTICAL  C-C(O)-, -CH2-W-C(=Y)-, or -W-CH2-CR5R6-; provided that when M = CR5R6, then Ar is not gp. (VI); R1 = H, methyl, -(CH2)m-O-R8, -C(O)-R9, -OR8, or -S(O)tR9; (ii) R2 = H or -OR8; R3 = H or lower alkyl; R4 = as R1 provided that at least one of R1 or R4 = H; R5, R6 = H, lower alkyl, or -(X)n-(CH2)p-R7; or R5+R6 = oxo, =S, oxime, or R11-O-N=, epoxy, cyclopropyl, cycloalkyl (opt. substd. by halo or lower alkyl) or -O-(CH2)q-O-; q = 2 or 3; R7 = H or -(CO)r-R10; R8 = H, lower alkyl or lower acyl; R9 = H, -NR'R'' or -OR11; R10 = H, alkyl, alkenyl, alkynyl, aryl, -NR'R'', or -OR11; R11 = H, 1-20C alkyl, mono- or poly-hydroxyalkyl, aryl or aralkyl (both opt. substd.), or an amino acid, peptide or sugar residue; R', R'' = H, lower alkyl, mono- or poly-hydroxyalkyl, aryl or aralkyl (both opt. substd.), or an amino acid, peptide or sugar residue; or R'+R'' = heterocycle; W = O, S or -NR12; R12 = H or methyl; X, Y = O or S; m, p = 0-10; provided that when R7 = -(CO)r-R10 and R10 = -OR11, then p cannot be 0; t = 0-2.
Patent AT-E156241-T1 (AT)
Inventor: HALSALL PHILIP STUART
IPC: F02B37/18
Filed: 1994-11-11
Granted: 1997-08-15
Abstract: PCT No. PCT/GB94/02482 Sec. 371 Date Sep. 8, 1995 Sec. 102(e) Date Sep. 8, 1995 PCT Filed Nov. 11, 1994 PCT Pub. No. WO95/13462 PCT Pub. Date May 18, 1995A turbocharger has a drive-shaft mounted in bearing means in a housing. The drive shaft drivably connects an exhaust gas driven turbine wheel to the impeller of an air compressor 22. A gas flow control device, such as a wastegate 10, 39 and/or a variable geometry turbine inlet nozzle, positioned upstream of the turbine wheel is operable to adjust the operating performance of the turbocharger. An electrically drivable actuator motor 17, 45, such as a D.C. motor or a stepper motor, is provided for regulating the operation of the gas flow control device via a linkage means 14, 15, 405, 407, 406, 825, 830, 835 in response to an electrical signal dependent at least upon the delivery pressure of the compressor. In a preferred arrangement the linkage means includes a relatively rotatable threaded lead screw 15 and a correspondingly threaded female screw member 14 threadably engaged therewith.
Patent AT-E319715-T1 (AT)
Inventor: COSTANZO MICHAEL J
IPC: A61K31/34
Filed: 1994-12-15
Granted: 2006-03-15
Abstract: A compound of general formula (I) is disclosed as a potent anticonvulsant drug. Pharmaceutical compositions and methods of treatment are also disclosed.
Patent AT-E172243-T1 (AT)
Inventor: TAKHAR GURINDER
IPC: C12M1/34
Filed: 1995-02-03
Granted: 1998-10-15
Abstract: PCT No. PCT/GB95/00219 Sec. 371 Date Sep. 16, 1996 Sec. 102(e) Date Sep. 16, 1996 PCT Filed Feb. 3, 1995 PCT Pub. No. WO95/21242 PCT Pub. Date Aug. 10, 1995A method of determining one or both of the colour and bitterness of beer by illuminating the beer with light of a pre-determined wavelength, typically 400+/-30 nm, to cause iso- alpha -acids in the beer to fluoresce. The fluorescence is detected over a range of wavelengths, typically 420 to 673 nm, using a fluorescence spectrophotometer. One or both of the colour and bitterness of the beer is determined by comparing an output signal from the fluorescence spectrophotometer to output signals stored for beers of known colour and bitterness.
Patent AT-E217121-T1 (AT)
Inventor: BARANOCHNIKOV MIKHAIL LVOVICH
IPC: H01L27/20
Filed: 1995-01-05
Granted: 2002-05-15
Abstract: A magnetically controlled logic cell comprising a semiconductor substrate (1) coated with a dielectric film and containing four field-effect transistors; four current supply buses in contact with the transistors and arranged on the surface of the dielectric film (17), two of the buses in question being power supply buses (34, 35), the other two being output buses (36, 37); and a region insulated from the substrate by a layer of concealed dielectric and by side insulation, the region in question containing four contacts configured symmetrically in pairs and connected to said transistors, power supply buses (34, 35) and output buses (36, 37). <IMAGE>
Patent AT-E211866-T1 (AT)
Inventor: GREEN MARTIN
IPC: H01R13/506
Filed: 1995-04-27
Granted: 2002-01-15
Abstract: A shielded connector assembly having a snap locking mounting scheme. The assembly includes a panel yoke (2) with snap locking elements (21) for snap lockingly, removably securing the panel yoke (2) in a panel or cover plate. The panel yoke (2) is also constructed to snap lockingly engage a shielding device (30) which in turn is constructed to snap lockingly engage a connector assembly comprising an interconnecting device (61) which may be a printed circuit board (59) including integrally defined reactive elements designed to compensate for reactive imbalance of electrical components connected thereto. A pair of wire termination blocks (70) mounted to a first side of the circuit board are connected by circuitry on the circuit board to a corresponding modular jack (60) mounted on a second side of the circuit board. The reactive elements produce an impedance between selected leads of the modular jack and the wire termination blocks by the circuitry. A snap locking combination of the shield device (30) and a shielding cover (90) completely shields the connector assembly (61). For joining the assembly parts, the shield includes pawls (32) and engagement members (33) that latch to cutouts (18) in the yoke and to apertures (94) in the shield cover, respectively. The shield device (30) includes a cable shield restraint (36). In one embodiment, a dual opening yoke receives two shielding devices. In another embodiment, a single opening yoke receives one shielding device.
Patent AT-E175996-T1 (AT)
Inventor: GROFFEN JOHN H
IPC: A01K67/027
Filed: 1995-05-12
Granted: 1999-02-15
Abstract: The invention relates to methods and kits for diagnosing cancers arising from cells which express tyrosine phosphorylated CRKL protein, such as cells having the Philadelphia (Ph) chromosome, which includes chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL), through the detection of increased levels of phosphorylated CRKL protein or through the detection of increased CRKL gene copy or mRNA expression. The invention also relates to methods of treating such cancers.
Patent AT-E235892-T1 (AT)
Inventor: VACHER DOMINIQUE
IPC: A61K9/00
Filed: 1995-07-13
Granted: 2003-04-15
Abstract: A method for preparing solid pharmaceuticals capable of virtually instantaneous disintegration for use in chemotherapy, wherein one or more active principles previously coated with a binder are mixed with a cellulose expanding agent and one or more water-soluble diluents before powder compression. Solid pharmaceuticals may thus be prepared.
Patent AT-E228155-T1 (AT)
Inventor: ELLINGSEN OLAV
IPC: B02C17/16
Filed: 1995-09-08
Granted: 2002-12-15
Abstract: A method for thermo-mechanical cracking and hydrogenation of chemical substances such as hydrocarbons in liquid or solid form, waxes, carbonates, lime, oil-shale, oil-sand, oily residue from refineries and crude tank bottoms, plast and the like. The cracking and the hydrogenating of the substances in the presence of hydrogen releasing chemicals as water is performed in a mechanical established fluidized bed (8) of fine grained solids where the mechanical action in the fluidized bed (8) generates the heat participating in the cracking in addition to the mechanical action to the substances whereby the cracking in the cavitating micro bubbles and the hydrogenation takes place in the reactor (1) with an overall temperature and pressure lower than by conventional cracking and/or hydrogenation processes.
Patent AT-E248553-T1 (AT)
Inventor: SCHAER ANDREAS
IPC: A61B5/022
Filed: 1995-11-21
Granted: 2003-09-15
Abstract: PCT No. PCT/CH95/00274 Sec. 371 Date Feb. 25, 1998 Sec. 102(e) Date Feb. 25, 1998 PCT Filed Nov. 21, 1995 PCT Pub. No. WO97/18750 PCT Pub. Date May 29, 1997The cuff for a sphygmomanometer comprises a flexible cover having an approximately rectangular area when unrolled and comprising a first short side and a second short side. The cover contains an air chamber in its interior which is connectable to a monitoring device. It has fixing means on its surface for fixing the cuff around a body limb. A flap, both sides of which are coated with attaching means for temporary attachment to the holding means, is attached to the second short side of the cover which flap folds both to the one surface and the other surface of the cuff and is attachable thereto by its attaching means.
Patent AT-E211472-T1 (AT)
Inventor: HUDKINS ROBERT L
IPC: A61K31/407
Filed: 1995-10-03
Granted: 2002-01-15
Abstract: Disclosed herein are compounds referred to as "fused pyrrolocarbazoles" which possess a variety of functional pharmacological activities including effect on the function and/or survival of trophic factor responsive cells; inhibition of enzymatic activity; inhibition of inflammation-associated responses; inhibition of cell growth associated with hyperproliferative states; and inhibition of developmentally programmed motoneuron death.. The disclosed compounds are represented by the following general formula:   <CHEM> Methodologies for the synthetic production of fused pyrrolocarbazoles are also disclosed, as well as exemplary uses of the compounds.
Patent AT-E200257-T1 (AT)
Inventor: KOPETZKY ROBERT
IPC: B60R22/46
Filed: 1996-01-24
Granted: 2001-04-15
Abstract: A vehicle safety belt unit with belt tensioning has a drive shaft roller (19, 22), which contains a coupling hollow chamber (100) whose circumferential wall is a rotating contact surface (64). A coupling rotating element (65), fixed rigidly to the belt coiling roller (12), is located concentrically in the chamber and provides the coupling contact surface (66). Between rotating and coupling contact surfaces is an intermediate chamber, in which normally uncontacting coupling elements (68) are located. A rigid coupling is produced when the driveshaft roller begins to rotate, in the event of a release of the pressure source (16).
Patent AT-E192593-T1 (AT)
Inventor: EBERHARD HANS JOACHIM
IPC: G07C5/00
Filed: 1996-04-26
Granted: 2000-05-15
Abstract: The publications are packed unsorted in containers (2) fitted with coded radio transmitters (3) and at each destination (14) is a coded radio transmitter. Each van (1) is equipped with at least one portable reader (4) with a computer which reads and evaluates the signals from the transmitters as well as a signal from a navigation system (5). After evaluation of the signals by the computer the reader provides signals optically and/or acoustically. At the same time that it reads the GPS navigation signals the reader can correct them and the precise geometrical position of the van can be determined by supplying coded signals cyclically from the transmitter at the intended destination to the navigation system.
Patent AT-E224661-T1 (AT)
Inventor: HAHN THOMAS
IPC: A47F3/00
Filed: 1996-11-15
Granted: 2002-10-15
Abstract: The top part (1) consists of a top surface (2) and at least three sides (3-6) made of transparent glass panes. Each two panes are joined by their vertical end surfaces. At the join between two side surfaces, the end of a spindle (1) driven by an electric motor (11) is fixed to the bottom part (8). Each electric motor is connected to a joint electronic control (12) which controls the electric motors so that they evenly raise the top part from the showcase's closed state or lower it from its open state. A switch (13) controls the up and down movement of the top part.
Patent AT-E266762-T1 (AT)
Inventor: SHAH PRAVINCHANDRA KANTILAL
IPC: D06P1/44
Filed: 1996-12-28
Granted: 2004-05-15
Abstract: An aqueous dispersion of 0.1 to 15 percent by weight of at least one phosphate ester and a copolymer formed by the copolymerization of a monomer mixture comprising:     a) 0.1 to 15 percent by weight of at least one dicarboxylic acid, b) 0.1 to 10 percent by weight of at least one functional monomer is represented by the following formula: <CHEM> where R1, R2 and R3 are hydrogen or a methyl group, R4 is an alkyl containing 1 to 4 carbon atoms, n is 0 or 1, X is selected from the group consisting of hydrogen, carboxyl, phenyl, aryl, alkyl or alkaryl groups containing 1 to 30 atoms,  and Y is a nucleophilic group selected from -OH,  -NH2 or <CHEM> wherein R5 is a hydrogen, an alkyl containing 1-20 carbon atoms, or an aryl group, and c) more than 80% by weight of backbone monomers.
Patent AT-E234563-T1 (AT)
Inventor: MATTHEWS BERNARD TREVOR
IPC: A22C7/00
Filed: 1996-04-19
Granted: 2003-04-15
Abstract: The present application provides a cooked, extruded meat product comprising a meat extrudate having an outwardly facing surface, which meat extrudate is impregnated with an additive in an additive zone which extends inwardly from the surface to a depth of at least 1mm, typically 1-5mm. Said meat product may comprise a co-extruded layer of fat or meat emulsion disposed circumjacent the meat layer or core. The present invention also provides a method of making such an extruded meat product and apparatus for the same. <IMAGE>
Patent AT-E189173-T1 (AT)
Inventor: ROMMEL WOLFGANG
IPC: B65D59/00
Filed: 1996-04-04
Granted: 2000-02-15
Abstract: A protective component to be fitted on or in an especially rod-like object (1) with springy longitudinal blades (2) on its inner or outer wall is to be rationally producible and usable. To this end the protective component with its blades is axially open at both ends. In addition, a protective component in the form of a protective sleeve can be opened in order to be able to be pushed transversely on a rod-like object (1).
Patent AT-E317405-T1 (AT)
Inventor: MATYJASZEWSKI KRZYSZTOF
IPC: C08F12/08
Filed: 1996-03-19
Granted: 2006-02-15
Abstract: A new polymerization process (atom transfer radical polymerization, or ATRP) based on a redox reaction between a transition metal (e.g., Cu(I)/Cu(II), provides "living" or controlled radical polymerization of styrene, (meth)acrylates, and other radically polymerizable monomers. Using various simple organic halides as model halogen atom transfer precursors (initiators) and transition metal complexes as a model halogen atom transfer promoters (catalysts), a "living" radical polymerization affords (co)polymers having the predetermined number average molecular weight by [M]/[I] 0  (up to M n  > 10 5 ) and a surprisingly narrow molecular weight distribution (M w /M n ), as low as 1.15. The participation of free radical intermediates in ATRP is supported by end-group analysis and stereochemistry of the polymerization. In addition, polymers with various topologies (e.g., block, random, star, end-functional and in-chain functional copolymers [for example, of styrene and methyl (meth)acrylate]) have been synthesized using the present process. The polymeric products encompassed by the present invention can be widely used as plastics, elastomers, adhesives, emulsifiers, thermoplastic elastomers, etc.
Patent AT-E393217-T1 (AT)
Inventor: FOSTER W
IPC: C12N9/64
Filed: 1996-05-21
Granted: 2008-05-15
Abstract: Provided by the present invention are novel methods of factor IX protein recovery and purification, making use of anion exchange chromatography heparin-like resins, hydroxyapatite and immobilized metal affinity chromatography.
Patent AT-E223671-T1 (AT)
Inventor: OLSEN TERJE STEINAR
IPC: A47C1/035
Filed: 1996-06-14
Granted: 2002-09-15
Abstract: PCT No. PCT/NO96/00146 Sec. 371 Date Apr. 6, 1998 Sec. 102(e) Date Apr. 6, 1998 PCT Filed Jun. 14, 1996 PCT Pub. No. WO97/00035 PCT Pub. Date Jan. 3, 1997Adjustable chair equipped with a calf supporting board which by means of an over-center mechanism and a gas spring can be brought to a horizontal position when the angle between the seat and the back of the seat increases, the board being foldable when the angle is decreased.
Patent AT-E194675-T1 (AT)
Inventor: STRAEHLE WERNER
IPC: E04B2/74
Filed: 1997-02-27
Granted: 2000-07-15
Abstract: The hollow box profile (1) has a steel strip which is reshaped roughly into a cuboid. The strip has stamped holes, and has longitudinal edges which are connected to one another. The edges of the strip butt against one another without overlapping, and the four edges (6) of the profile are rounded and stiffened. The rounding and stiffening may be achieved by hollow mouldings or crimps on the edges. At least the broad sides (2,2') of the profile may have crimps (8) which bulge outwards, and which run parallel to the edges.
Patent AT-E220564-T1 (AT)
Inventor: ATKINSON BRENT A
IPC: A61L27/00
Filed: 1997-08-14
Granted: 2002-08-15
Abstract: The composition as described serves for in vivo cartilage repair. It basically consists of a naturally derived osteoinductive and/or chondroinductive mixture of factors (e.g. derived from bone) or of a synthetic mimic of such a mixture combined with a nanosphere delivery system. A preferred mixture of factors is the combination of factors isolated from bone, known as BP and described by Poser and Benedict (WO 95/13767). The nanosphere delivery system consists of nanospheres defined as polymer particles of less than 1000 nm in diameter (whereby the majority of particles preferably ranges between 200-400 nm) in which nanospheres the combination of factors is encapsulated. The nanospheres are loaded with the mixture of factors in a weight ratio of 0.001 to 17% (w/w), preferably of 1 to 4% (w/w) and have a release profile with an initial burst of 10 to 20% of the total load over the first 24 hours and a long time release of at least 0.1 per day during at least seven following days. The nanospheres are composed of e.g. ((D,L)-lactic acid / glycolic acid)-copolymer (PLGA). The loaded nanospheres are e.g. made by phase inversion. The composition is advantageously utilized as a device comprising any biodegradable matrix in which the nanospheres loaded with the factor combination is contained. <IMAGE>
Patent AT-E211491-T1 (AT)
Inventor: FOLLESTAD ARILD
IPC: C08F4/42
Filed: 1997-01-23
Granted: 2002-01-15
Abstract: A process for the polymerization of ethylene and optionally alpha-olefins to form ethylene homopolymer or copolymers having a broad molecular weight distribution, comprising polymerization of 100-80 wt. % of ethylene and 0-20 wt. % of comonomer in the presence of two independent, simultaneously present catalysts A and B, wherein catalyst A, deposited on an inorganic support, comprises chromium in a predominantly oxidant state of 2 and catalyst B comprises a bis-cyclopentadienyl chromium compound reacted with an inorganic support.
Patent AT-E239455-T1 (AT)
Inventor: SVEDMAN PAL
IPC: A61M35/00
Filed: 1997-03-19
Granted: 2003-05-15
Abstract: The invention provides a transdermal device suitable for continuous administration of an opiate/opioid analgesic for a period of about 24 to about 144 hours via an area of skin for which the epidermis has been removed. The device has incorporated therein from 11 to 3000 mg of morphine or a salt thereof or from 11/P to 3000/P mg of another opiate/opioid analgesic for which P is the level of analgesic effect of said other opiate/opioid analgesic relative to morphine.
Patent AT-E208019-T1 (AT)
Inventor: BRUEGGEMANN HANS
IPC: F01M11/00
Filed: 1997-03-21
Granted: 2001-11-15
Abstract: PCT No. PCT/EP97/01444 Sec. 371 Date Apr. 29, 1999 Sec. 102(e) Date Apr. 29, 1999 PCT Filed Mar. 21, 1997 PCT Pub. No. WO97/41373 PCT Pub. Date Nov. 6, 1997A valve for liquids including a valve housing (10) and a valve body (13) which is guided in the housing, and at least one releasable catch (16) which engages the valve body and holds the valve body in an open position in the valve housing until liquid starts to pass through the valve.
Patent AT-E299030-T1 (AT)
Inventor: KIKUCHI MAKOTO
IPC: A61K35/28
Filed: 1997-07-10
Granted: 2005-07-15
Abstract: The present invention provides novel use of the MK family that is used alone as an agent for proliferating hematopoietic stem cells and hematopoietic precursor cells. The invention also provides an agent for remarkably enhancing the above-described effect for promoting the proliferation of hematopoietic stem cells and hematopoietic precursor cells, comprising the MK family in combination with known hematopoietic factors such as IL-3, IL-6, G-CSF, GM-CSF, M-CSF, SCF, and EPO.
Patent AT-E218839-T1 (AT)
Inventor: MOGENSEN BENT
IPC: A61C9/00
Filed: 1997-09-10
Granted: 2002-06-15
Abstract: PCT No. PCT/DK97/00382 Sec. 371 Date Mar. 9, 1999 Sec. 102(e) Date Mar. 9, 1999 PCT Filed Sep. 10, 1997 PCT Pub. No. WO98/10709 PCT Pub. Date Mar. 19, 1998A mould for casting a base for a dental model when reconstructing teeth for dentures or parts thereof and including a base plate along the edge of which a mould cavity is placed, the mould cavity including a bottom with fixating structures for the dental model or parts thereof, and walls provided with ribs extending from the bottom, the mould cavity having the shape of at least a part of a jaw. With a view to creating a stable mould, in which the model cast on the base may be remounted and positioned without rocking, the mould is designed in such a way that the fixation structures are at least substantially cylindrical pins which can be inserted in corresponding holes in the bottom of the mould cavity and which each include a portion suited for being cast in the base of the dental model.